PMID- 16315784 OWN - NLM STAT- MEDLINE DCOM- 20060126 LR - 20161021 IS - 1124-0490 (Print) IS - 1124-0490 (Linking) VI - 22 IP - 3 DP - 2005 Oct TI - National survey on status of steroid therapy for cardiac sarcoidosis in Japan. PG - 210-3 AB - AIM: This investigation was undertaken to clarify the current status of steroid therapy for cardiac sarcoidosis in Japan. METHODS: A questionnaire survey was conducted throughout Japan concerning cases in which steroid therapy had been administered. Replies describing 52 cases (15 men, 37 women; mean age +/- SD, 59.8 +/- 14.5 years) were analyzed. RESULTS: Of the 49 patients whose New York Heart Association (NYHA) functional classification was reported, 29 (55.8%) were in class I; 13 (25.0%) class II; 4 (7.7%) class III and 3 (5.8%) class IV. The most common initial steroid dose (used in 35 cases, or 67.3%) was 30 mg/day or 60 mg on alternate days. In most cases (85.4%), this dose was continued for 1 month followed by tapering by 5 mg every 2 to 4 weeks until reaching the maintenance dose of 5 to 10 mg/day. Steroid therapy was reported to result in improvement in 54%, no change in 40%, and deterioration in 6%. CONCLUSION: This nationwide questionnaire survey indicated fairly uniform patterns of steroid therapy for cardiac sarcoidosis in Japan, with clinical improvement in over one-half of cases and possible stabilization in most others. FAU - Hiramitsu, Shinya AU - Hiramitsu S AD - Division of Cardiology, Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan. FAU - Morimoto, Shin-ichiro AU - Morimoto S FAU - Uemura, Akihisa AU - Uemura A FAU - Kato, Yasuchika AU - Kato Y FAU - Kimura, Katsutomo AU - Kimura K FAU - Ohtsuki, Masatsugu AU - Ohtsuki M FAU - Kato, Shigeru AU - Kato S FAU - Sugiura, Atsushi AU - Sugiura A FAU - Miyagishima, Kenji AU - Miyagishima K FAU - Hishida, Hitoshi AU - Hishida H FAU - Sugisaki, Katsunori AU - Sugisaki K FAU - Tsuda, Tomiyasu AU - Tsuda T LA - eng PT - Journal Article PL - Italy TA - Sarcoidosis Vasc Diffuse Lung Dis JT - Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG JID - 9610928 RN - 0 (Glucocorticoids) RN - 9PHQ9Y1OLM (Prednisolone) SB - IM MH - Adult MH - Aged MH - Cardiomyopathies/classification/*drug therapy MH - Drug Administration Schedule MH - Female MH - Glucocorticoids/administration & dosage/therapeutic use MH - Health Care Surveys MH - Heart Block/etiology MH - Humans MH - Japan MH - Male MH - Middle Aged MH - Prednisolone/administration & dosage/*therapeutic use MH - Sarcoidosis/classification/*drug therapy EDAT- 2005/12/01 09:00 MHDA- 2006/01/27 09:00 CRDT- 2005/12/01 09:00 PHST- 2005/12/01 09:00 [pubmed] PHST- 2006/01/27 09:00 [medline] PHST- 2005/12/01 09:00 [entrez] PST - ppublish SO - Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):210-3.